4/A//SEC Filing
Dukes Iain D. 4/A
Accession 0000929638-24-002743
CIK 0001130598other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 3:47 PM ET
Size
5.3 KB
Accession
0000929638-24-002743
Insider Transaction Report
Form 4/AAmended
Dukes Iain D.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-04-01+67,500→ 134,187 total
Footnotes (2)
- [F1]On April 3, 2024, the reporting person filed a Form 4 that inadvertently reported the number of shares of common stock (the "Common Stock") of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.) underlying a grant of restricted stock units as 67,550 instead of 67,500. Nevertheless, the number of shares of Common Stock beneficially owned following the reported transaction was correctly reported in the original Form 4 as 134,187.
- [F2]Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into shares of Common Stock on a one-for-one basis.
Documents
Issuer
Traws Pharma, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001681955
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 3:47 PM ET
- Size
- 5.3 KB